Two medical students at the Jacobs School of Medicine and Biomedical Sciences have been elected to top positions of a national student-run otolaryngology newsletter created by and for medical students.
Asim Khan, PhD, a nationally recognized expert in digital technologies and strategic health care information leader, has been named the University at Buffalo’s health sciences chief data and information officer, effective Sept. 2.
The Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo hosted an international conference on cerebrovascular disease July 31-Aug.2.
Indigenous middle school, high school and college students got a varied and detailed hands-on look at health care careers during the third annual 7th Generation Operation event July 23 at the Jacobs School of Medicine and Biomedical Sciences.
Ellen E. Lutnick, MD ’21, a PGY-4 resident in the Department of Orthopaedics, Jacobs School of Medicine and Biomedical Sciences, had two studies showcased at the recent annual American Orthopaedic Association conference in June.
An NIH-funded study will aim to determine whether the circadian clock present inside each cardiac cell can be a viable therapeutic target for treatment of sudden cardiac arrest (SCA) and life-threatening arrhythmias.
An endowed chair in the Department of Psychiatry at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo will honor Emeritus Professor Barry S. Willer, PhD.
New medical students from the Jacobs School of Medicine and Biomedical Sciences Class of 2029 celebrated beginning medical school with a traditional White Coat Ceremony on July 18 held at UB’s Center for the Arts on the North Campus.
Six Jacobs School of Medicine and Biomedical Sciences faculty members were cited as among UB’s best and brightest teachers and researchers by being named recipients of the university’s 2025 Exceptional Scholar and Teaching Innovation Awards.
Gil I. Wolfe, MD, SUNY Distinguished Professor of neurology, is lead author on a New England Journal of Medicine editorial discussing a recent clinical trial aimed at treating the neurologic disorder myasthenia gravis (MG).